Related Experiment Video

Updated: Jul 11, 2026

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

Apoptin: therapeutic potential of an early sensor of carcinogenic transformation

Claude Backendorf1, Astrid E Visser, A G de Boer

  • 1Molecular Genetics, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands. backendo@chem.leidenuniv.nl

Annual Review of Pharmacology and Toxicology
|September 13, 2007
PubMed

Insights

Apoptin, a tumor-specific protein, triggers cancer cell death independently of p53. It shows promise as a safe and effective antitumor agent, leading to tumor regression in animal models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Apoptin, derived from an avian virus, induces apoptosis in tumor cells.
  • Apoptin functions as a multimeric complex, forming superstructures upon DNA binding.
  • Apoptin's activity is regulated by phosphorylation and cellular localization, differing between tumor and normal cells.

Purpose of the Study:

  • To investigate the tumor-specific apoptosis-inducing mechanism of apoptin.
  • To explore apoptin's potential as an anticancer therapeutic agent.
  • To understand how apoptin recognizes and targets cancer cells.

Main Methods:

  • Studied apoptin's interaction with DNA and its multimeric complex formation.
  • Analyzed apoptin phosphorylation and nuclear translocation in tumor versus normal cells.
  • Utilized apoptin-transgenic mice and animal tumor models to assess antitumor efficacy.

Main Results:

  • Apoptin induces p53-independent apoptosis specifically in tumor cells.
  • Phosphorylation and nuclear localization of apoptin are key for its activity in tumor cells.
  • Apoptin targets include DEDAF, Nur77, Nmi, Hippi, and APC1.
  • Apoptin demonstrated significant tumor regression in animal models, indicating safety and efficacy.

Conclusions:

  • Apoptin recognizes early stages of oncogenic transformation and redirects survival signals into cell death.
  • Apoptin represents a promising therapeutic agent for cancer treatment.
  • Future therapies may utilize apoptin as a targeted drug or a sensor for tumor-specific processes.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Detection and Analysis of DNA Damage in Mouse Skeletal Muscle In Situ Using the TUNEL Method09:54

Detection and Analysis of DNA Damage in Mouse Skeletal Muscle In Situ Using the TUNEL Method

Published on: December 16, 2014

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...